NorthWest Biotherapeutics Inc (NWBO)

[CogDiss 1188X]

Here’s the NCI meeting notes were data sharing was discussed:

Dr. Sharpless reported on recent visits with U.S. Food and Drug Administration (FDA) Commissioner, Dr. Scott Gottlieb, and Centers for Medicare and Medicaid Services (CMS) Administrator, Ms. Seema Verma. The commitment and interest in data sharing was a crosscutting theme of these meetings, as was both the agencies’ enthusiasm for ongoing collaborations with the NCI. The CMS, realizing its strong engagement and long history with the NCI on data sharing, also recognizes a need for enhanced commitments. Dr. Sharpless remarked that the CMS and FDA have accumulated data that are of great interest to the cancer research community and that the NCI is actively discussing with both agencies an appropriately secure mechanism to best make these data publicly available. During his visit to the CMS, Dr. Sharpless also discussed the proposed coverage-related decision regarding next-generation sequencing (NGS) to manage care of cancer patients (i.e., Medicare beneficiaries) with solid tumors of advanced cancer (i.e., metastatic disease). The CMS national coverage.

https://deainfo.nci.nih.gov/advisory/ncab/0218/minutes.pdf